Brief: Auris Medical Announces Positive Preclinical and Clinical Outcomes with AM-301

Altamira Therapeutics

13/04/2021 15:06

April 13 (Reuters) - Auris Medical Holding Ltd  EARS.O :
    * AURIS MEDICAL ANNOUNCES POSITIVE PRECLINICAL AND CLINICAL
OUTCOMES WITH AM-301 AND DETAILS PLANS FOR MARKET LAUNCH
    * AURIS MEDICAL HOLDING LTD - PRELIMINARY PRECLINICAL DATA
SUGGEST
THERAPEUTIC UTILITY POST SARS-COV-2 INFECTION
    * AURIS MEDICAL HOLDING LTD - EXTENDED PROTECTION ACHIEVED
OVER
SEVERAL HOURS
    * AURIS MEDICAL HOLDING LTD - CLINICAL EVALUATION OF AM-301
NASAL
SPRAY IN ALLERGIC RHINITIS MEETS PRIMARY ENDPOINT
    * AURIS MEDICAL HOLDING LTD - PRODUCT LAUNCH UNDER BENTRIO
BRAND
IN SELECTED EUROPEAN COUNTRIES TOWARDS END OF Q2 2021

Source text for Eikon:  ID:nGNX9SPp5X 
Further company coverage:  EARS.O 

 ((Reuters.Briefs@thomsonreuters.com;))